Showing results (91-100 of 463) with videos related to
Sort By:
Pageof 47
Psychopharmacology|March 25, 2011
Effectiveness and costs of flupentixol compared to other first- and second-generation antipsychotics in the treatment of schizophreniaTom Stargardt, Paraskevi Mavrogiorgou, Christian A Gericke, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 22, 2021
Impact of Poly I:C induced maternal immune activation on offspring's gut microbiome diversity - Implications for schizophreniaGeorg Juckel, Marie-Pierre Manitz, Nadja Freund, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 23, 2020
Induction of inducible nitric oxide synthase expression in activated microglia and astrocytes following pre- and postnatal immune challenge in an animal model of schizophreniaAwatef Esshili, Marie-Pierre Manitz, Nadja Freund, et al.Psychiatrische Praxis|October 17, 2008
[Combination of dialectic and behavioral therapy (DBT) and duloxetin in kleptomania]Astrid Rudel, Cornelia Hubert, Georg Juckel, et al.Psychiatrische Praxis|August 7, 2008
[Schizophrenia and religiousness--a comparative study at the time of the two German states]Michael Pfaff, Boris B Quednow, Martin Brüne, et al.Biological Psychology|June 10, 2015
Performance monitoring and empathy during active and observational learning in patients with major depressionPatrizia Thoma, Christine Norra, Georg Juckel, et al.Psychiatry Research|March 17, 2018
Alexithymia in borderline personality disorder is not associated with deficits in automatic visual processing of negative emotional stimuliStoyan Popkirov, Vera Flasbeck, Uwe Schlegel, et al.Psychopathology|March 3, 2021
Pareidolias and Creativity in Patients with Mental DisordersParaskevi Mavrogiorgou, Nils Peitzmeier, Björn Enzi, et al.Psychiatry Investigation|February 26, 2020
Skin Diseases in Patients with Primary Psychiatric DisordersParaskevi Mavrogiorgou, Corinna Mersmann, Gabriele Gerlach, et al.Pageof 47